PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $63,000 | -6.0% | 101,617 | 0.0% | 0.00% | – |
| Q1 2017 | $67,000 | +116.1% | 101,617 | 0.0% | 0.00% | – |
| Q4 2016 | $31,000 | -27.9% | 101,617 | -0.0% | 0.00% | – |
| Q3 2016 | $43,000 | +16.2% | 101,619 | 0.0% | 0.00% | – |
| Q2 2016 | $37,000 | -96.5% | 101,619 | -96.0% | 0.00% | – |
| Q1 2016 | $1,070,000 | -62.5% | 2,546,696 | +4.4% | 0.00% | – |
| Q4 2015 | $2,854,000 | +17.5% | 2,440,069 | +2.5% | 0.00% | – |
| Q3 2015 | $2,429,000 | -23.5% | 2,381,043 | -1.7% | 0.00% | – |
| Q2 2015 | $3,176,000 | +4.6% | 2,423,438 | +7.8% | 0.00% | – |
| Q1 2015 | $3,036,000 | -2.2% | 2,248,886 | +0.6% | 0.00% | – |
| Q4 2014 | $3,105,000 | +5.1% | 2,234,885 | +2.8% | 0.00% | – |
| Q3 2014 | $2,954,000 | -27.0% | 2,173,530 | +1.0% | 0.00% | – |
| Q2 2014 | $4,046,000 | -1.1% | 2,152,610 | -0.1% | 0.00% | – |
| Q1 2014 | $4,092,000 | +59.1% | 2,153,838 | +16.2% | 0.00% | – |
| Q4 2013 | $2,572,000 | +16.4% | 1,854,205 | +18.5% | 0.00% | – |
| Q3 2013 | $2,209,000 | +26.7% | 1,565,150 | +15.6% | 0.00% | – |
| Q2 2013 | $1,744,000 | – | 1,353,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 148,006 | $206,000 | 0.10% |
| First Heartland Consultants, Inc. | 86,204 | $120,000 | 0.07% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $934,000 | 0.02% |
| Investors Capital Advisory Services | 47,238 | $65,000 | 0.02% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $28,000 | 0.01% |
| Commonwealth Equity Services, Inc | 481,140 | $669,000 | 0.01% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $16,000 | 0.01% |
| First Allied Advisory Services, Inc. | 50,000 | $70,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 13,200 | $18,000 | 0.01% |
| AMALGAMATED BANK | 16,650 | $23,000 | 0.00% |